|
1
|
Benson JR and Jatoi I: The global breast
cancer burden. Future Oncol. 8:697–702. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nandy A, Gangopadhyay S and Mukhopadhyay
A: Individualizing breast cancer treatment-The dawn of personalized
medicine. Exp Cell Res. 320:1–11. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Slamon DJ, Leyland-Jones B, Shak S, Fuchs
H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M,
et al: Use of chemotherapy plus a monoclonal antibody against HER2
for metastatic breast cancer that overexpresses HER2. N Engl J Med.
344:783–792. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lim E and Winer EP: Adjuvant chemotherapy
in luminal breast cancers. Breast. 20 Suppl 3:S128–131. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu ZM, Chen GG, Vlantis AC, Liang NC,
Deng YF and van Hasselt CA: Cell death induced by
ent-11alpha-hydroxy-15-oxo-kaur-16-en-19-oic-acid in anaplastic
thyroid carcinoma cells is via a mitochondrial-mediated pathway.
Apoptosis. 10:1345–1356. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brunocolmenarez J, Peña A, Alarcón L,
Usubillaga A and Delgadoméndez P: Structure of
ent-15a-hydroxy-kaur-16-en-19-oic acid. Avances En Química.
6:16–20. 2011.
|
|
7
|
Li L, Chen GG, Lu YN, Liu Y, Wu KF, Gong
XL, Gou ZP, Li MY and Liang NC:
Ent-11α-Hydroxy-15-oxo-kaur-16-en-19-oic-acid inhibits growth of
human lung cancer A549 cells by arresting cell cycle and triggering
apoptosis. Chin J Cancer Res. 24:109–115. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen GG, Leung J, Liang NC, Li L, Wu K,
Chan UP, Leung BC, Li M, Du J, Deng YF, et al:
Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid inhibits
hepatocellular carcinoma in vitro and in vivo via stabilizing IkBα.
Invest New Drugs. 30:2210–2218. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Z, Ng EK, Liang NC, Deng YF, Leung BC
and Chen GG: Cell death induced by Pteris semipinnata L. Is
associated with p53 and oxidant stress in gastric cancer cells.
FEBS Lett. 579:1477–1487. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen GG, Liang NC, Lee JF, Chan UP, Wang
SH, Leung BC and Leung KL: Over-expression of Bcl-2 against Pteris
semipinnata L-induced apoptosis of human colon cancer cells via a
NF-kappa B-related pathway. Apoptosis. 9:619–627. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vlantis AC, Lo CS, Chen GG, Liang Ci N,
Lui VW, Wu K, Deng YF, Gong X, Lu Y, Tong MC and van Hasselt CA:
Induction of laryngeal cancer cell death by
Ent-11-hydroxy-15-oxo-kaur-16-en-19-oic acid. Head Neck.
32:1506–1518. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mgbonyebi OP, Russo J and Russo IH:
Roscovitine induces cell death and morphological changes indicative
of apoptosis in MDA-MB-231 breast cancer cells. Cancer Res.
59:1903–1910. 1999.PubMed/NCBI
|
|
13
|
Chen JF, Chen YX, Li P, Fu M, Lv YN and Li
L: Effect of Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid on human
gastric cancer cells and its mechanism. Nan Fang Yi Ke Da Xue Xue
Bao. 31:1345–1348. 2011.(In Chinese). PubMed/NCBI
|
|
14
|
Crépin M, Salle V, Raux H, Berger R,
Hamelin R, Brouty-Boyé D and Israel L: Steroid hormone receptors
and tumorigenicity of sublines from breast tumor metastatic MDA-MB
231 cell line. Anticancer Res. 10:1661–1666. 1990.PubMed/NCBI
|
|
15
|
Duncan RE and Archer MC: Farnesol induces
thyroid hormone receptor (THR) beta1 but inhibits THR-mediated
signaling in MCF-7 human breast cancer cells. Biochem Biophys Res
Commun. 343:239–243. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Reed JC: Dysregulation of apoptosis in
cancer. J Clin Oncol. 17:2941–2953. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gupta S: Molecular steps of death receptor
and mitochondrial pathways of apoptosis. Life Sci. 69:2957–2964.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pinton P, Ferrari D, Rapizzi E, Di
Virgilio F, Pozzan T and Rizzuto R: The Ca2+ concentration of the
endoplasmic reticulum is a key determinant of ceramide-induced
apoptosis: Significance for the molecular mechanism of Bcl-2
action. EMBO J. 20:2690–2701. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gross A, McDonnell JM and Korsmeyer SJ:
BCL-2 family members and the mitochondria in apoptosis. Genes Dev.
13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eldering E, Mackus WJ, Derks IA, Evers LM,
Beuling E, Teeling P, Lens SM, van Oers MH and van Lier RA:
Apoptosis via the B cell antigen receptor requires Bax
translocation and involves mitochondrial depolarization, cytochrome
C release, and caspase-9 activation. Eur J Immunol. 34:1950–1960.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen F, Jiang X, Chen X, Liu G and Ding J:
Effects of downregulation of inhibin alpha gene expression on
apoptosis and proliferation of goose granulosa cells. J Genet
Genomics. 34:1106–1113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pilchova I, Klacanova K, Chomova M,
Tatarkova Z, Dobrota D and Racay P: Possible contribution of
proteins of Bcl-2 family in neuronal death following transient
global brain ischemia. Cell Mol Neurobiol. 35:23–31. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo B, Zhai D, Cabezas E, Welsh K,
Nouraini S, Satterthwait AC and Reed JC: Humanin peptide suppresses
apoptosis by interfering with Bax activation. Nature. 423:456–461.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li MY, Liang NC and Chen GG:
Ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid induces apoptosis of
human malignant cancer cells. Curr Drug Targets. 13:1730–1737.
2012. View Article : Google Scholar : PubMed/NCBI
|
